欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/0469/001
药品名称
Lisinopril/hydrochlorthiazid "Sandoz"
活性成分
hydrochlorothiazide dihydrate 13.0 mg
lisinopril dihydrate 10.0 mg
剂型
Tablet
上市许可持有人
Sandoz GmbH Biochemiestrasse 10 A-6250 Kundl Austria
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
许可日期
2003/10/10
最近更新日期
2024/03/19
药物ATC编码
C09AA03 lisinopril
C03AA03 hydrochlorothiazide
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Generic Article 4.8(a)(iii), first paragraph
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
Common PIL Ciprofloxacin Pharmathen _ clean
Date of last change:2022/09/12
Final SPC
|
Lisinopril-Hydrochlorthiazid_SPC_common_clean
Date of last change:2019/06/04
Final Product Information
|
common-pl -clean
Date of last change:2019/01/10
Final Product Information
|
common-spc-clean
Date of last change:2019/01/10
Final Labelling
|
1.3.1 spc-label-pl - common-outer - 3,827_clean
Date of last change:2017/09/27
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase